Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Solesence (SLSN) Common Equity (2016 - 2025)

Historic Common Equity for Solesence (SLSN) over the last 16 years, with Q3 2025 value amounting to $17.2 million.

  • Solesence's Common Equity rose 1356.71% to $17.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.2 million, marking a year-over-year increase of 1356.71%. This contributed to the annual value of $14.9 million for FY2024, which is 68580.44% up from last year.
  • According to the latest figures from Q3 2025, Solesence's Common Equity is $17.2 million, which was up 1356.71% from $18.2 million recorded in Q2 2025.
  • In the past 5 years, Solesence's Common Equity ranged from a high of $18.2 million in Q2 2025 and a low of $1.9 million during Q4 2023
  • Moreover, its 5-year median value for Common Equity was $7.5 million (2021), whereas its average is $8.8 million.
  • As far as peak fluctuations go, Solesence's Common Equity plummeted by 6633.03% in 2023, and later soared by 68580.44% in 2024.
  • Solesence's Common Equity (Quarter) stood at $7.5 million in 2021, then decreased by 24.33% to $5.6 million in 2022, then tumbled by 66.33% to $1.9 million in 2023, then soared by 685.8% to $14.9 million in 2024, then grew by 15.26% to $17.2 million in 2025.
  • Its Common Equity was $17.2 million in Q3 2025, compared to $18.2 million in Q2 2025 and $15.2 million in Q1 2025.